KRS 439.655: Suspension from and resumption of pilot program participation.

If reentry drug supervision pilot program participation as outlined in KRS 439.654 is

impracticable due to inpatient treatment or similar circumstances in which the

participant is being monitored by an authorized third party, the participant shall be

placed in suspended status. Upon release from the authorized third party, the

participant shall resume participation in the reentry drug supervision pilot program.

During the time in which the participant is suspended, no credit shall be earned

toward the completion of the two (2) pilot program phases.